Hristio Boytchev is an investigative health journalist. He was part of the "EurosFürÄrzte" team at "Correctiv", a database of pharma payments to doctors. He leads "FollowTheGrant", an investigative tool based on academic conicts of interest. Hristio holds numerous awards and was voted the N°3 German science journalist in 2016.

Basic information

Hristio Boytchev
Investigative health and science journalism

Supported projects

Behind The Pledge - How EU money is spent for Covid19 drugs

  • Healthcare
  • Industry

BRUSSELS - How did we come to pay gold for a drug whose effectiveness has not been proven? This is the story of Remdesivir, a drug developed by the American company Gilead Sciences with large public funds to combat Ebola, and in July approved by the European Medicines Agency with "conditional authorisation" as the first antiviral against Covid 19.